ATH 0.00% 0.3¢ alterity therapeutics limited

Ann: Appendix 3B , page-24

  1. 6,154 Posts.
    lightbulb Created with Sketch. 1641
    I would be a little careful about chart interpretations. Fundamentals some times come into play.

    The pull back you mentioned could have been influenced by the announcement of the Prospectus for the issue of $47 million of ADR's.. This was compounded 2 weeks later with a further announcement of the delay in REACH trial results. The (up till then) rampaging SP took a huge hit over this period. I don't see such a scenerio unfolding atm.

    IMO, an Appendix 3B for the issue of a chunk of those ADR'S, is the principal risk to the SP taking a hit pre upcoming REACH results.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $4.579K 1.526M

Buyers (Bids)

No. Vol. Price($)
2 749591 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 133062022 26
View Market Depth
Last trade - 14.03pm 13/09/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.